Richard G. Vincent - 27 Jan 2022 Form 4 Insider Report for Oncternal Therapeutics, Inc.

Role
Chief Financial Officer
Signature
/s/Chase C. Leavitt, Attorney-in-fact
Issuer symbol
N/A
Transactions as of
27 Jan 2022
Net transactions value
+$21,625
Form type
4
Filing time
31 Jan 2022, 15:00:22 UTC
Previous filing
24 Jan 2022
Next filing
28 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ONCT Common Stock Purchase $9,000 +5,000 +7.1% $1.80 75,662 27 Jan 2022 Direct
transaction ONCT Common Stock Purchase $8,500 +5,000 +6.6% $1.70 80,662 27 Jan 2022 Direct
transaction ONCT Common Stock Purchase $4,125 +2,500 +3.1% $1.65 83,162 28 Jan 2022 Direct
holding ONCT Common Stock 4,526 27 Jan 2022 By Family Trust
holding ONCT Common Stock 1,834 27 Jan 2022 By Child
* An asterisk sign (*) next to the price indicates that the price is likely invalid.